High-sensitivity troponin (hs-Tn) for cardiovascular risk prognostication: a systematic review and meta-analysis

26 August 2022 (08:00 - 19:30)

Organised by:

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Marios Sagris

Hippokration General Hospital, Athens (Greece)

7 More presentations in this session

Presentation thumbnail

Long-term prognostic value of trimethylamine N-oxide in community-based adults and patients with coronary heart disease

Doctor E. Bjornestad (Stavanger, NO)

Abstract Slides

Presentation thumbnail

Ultra-sensitive troponin-I and incident coronary heart disease, stroke, heart failure, cardiac arrhythmias, arterial aneurysms and venous thromboembolism hospitalizations

Professor J. Empana (Paris, FR)

Abstract Slides

Presentation thumbnail

The effect of ziltivekimab on the neutrophil-lymphocyte ratio: analysis from RESCUE

Doctor N. Adamstein (Boston, US)

Abstract Slides

Presentation thumbnail

High-sensitive Troponin T is not associated with the progression of asymptomatic mild to moderate aortic stenosis: a post hoc substudy of the SEAS trial

Doctor E. Hadziselimovic (Copenhagen, DK)

Abstract Slides

Presentation thumbnail

Elevated high-sensitivity C-reactive protein and the risk for cardiovascular events in chronic cardiac disease

Professor J. Bergler-Klein (Vienna, AT)

Abstract Slides

Access the full session

Session thumbnail

Cardiovascular risk assessment - Biomarkers 2

The Event

Event poster

ESC Congress 2022

26 August - 29 August 2022

You may be interested in

Congress Presentation

Advancements and challenges in cardiovascular risk stratification: an overview of cardiac biomarkers

Webinar

Biomarkers of clinical utility in cardiovascular disease

Congress Session

Challenges and innovations in cardiovascular risk stratification with cardiac biomarkers

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources